Automated measurement method for the determination of vitamin e in plasma lipoprotein classes

Scientific Reports

Volumn 4, Issue , 2014, Pages

  Hirowatari, Yuji ^a   Yoshida, Hiroshi ^b   Kurosawa, Hideo ^c   Manita, Daisuke ^a   Tada, Norio ^b  

^a TOSOH CORPORATION   (Japan)

^b JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c Inzai General Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; GAMMA TOCOPHEROL; HIGH DENSITY LIPOPROTEIN; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN;

ADULT; AUTOMATION; BLOOD; BLOOD ANALYSIS; DEVICES; DYSLIPIDEMIA; HUMAN; ION EXCHANGE CHROMATOGRAPHY; ISOLATION AND PURIFICATION; METABOLISM; MIDDLE AGED; PATHOLOGY; PROCEDURES; REVERSED PHASE LIQUID CHROMATOGRAPHY; SPECTROFLUOROMETRY;

ADULT; ALPHA-TOCOPHEROL; AUTOMATION; BLOOD CHEMICAL ANALYSIS; CHROMATOGRAPHY, ION EXCHANGE; CHROMATOGRAPHY, REVERSE-PHASE; DYSLIPIDEMIAS; GAMMA-TOCOPHEROL; HUMANS; LIPOPROTEINS; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; MIDDLE AGED; SPECTROMETRY, FLUORESCENCE; VITAMIN E;

EID: 84920525716     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep04086     Document Type: Article

References (32)

1. Moore, K. J. & Tabas, I. The cellar biology of macrophages in atherosclesosis. Cell. 145, 341-355 (2011).
2. Steinberg, D. Atherogenesis in perspective: hypercholesterolemia and inflammation as partners in crime. Nat Med. 8, 1211-1217 (2002).
3. Glass, C. K. & Witztum, J. L. Atherosclerosis: the road ahead. Cell. 104, 503-516 (2001).
4. Oorni, K., Posio, P., Ala-Korpela, M., Jauhiainen, M. & Kovanen, P. T. Sphingomyelinase induces aggregation and fusion of small very low-density lipoprotein and intermediate-density lipoprotein particles and increases their retention to human arterial proteoglycans. Arterioscler Thromb Vasc Biol. 25, 1678-1683 (2005).
5. Orekhov, A. N. et al. Blood serum atherogenicity associated with coronary atherosclerosis. Circ Res. 62, 421-429 (1988).
6. Whitman, S. C., Sawyez, C. G.,Miller, D. B.,Wolfe, B. M. & Huff, M. W. Oxidized type IV hypertriglyceridemic VLDL-remnants cause greater macrophage cholesteryl ester accumulation than oxidized LDL. J Lipid Res. 39, 1008-1020 (1998).
7. Nadeem, N. et al. The two faces of a- and c-tocopherols: an in vitro and ex vivo investigation into VLDL, LDL and HDL oxidation. J Nutr Biochem. 23, 845-851 (2012).
8. Wen, Y., Killalea, S., Norris, L. A., Cooke, T. & Feely, J. Vitamin E supplementation in in hyperlipidemic patients: effect of increasing doses on in vitro and in vivo low-density lipoprotein oxidation. Eur J Clin Invest. 29, 1027-1034 (1999).
9. Suzukawa, M., Ishikawa, T., Yoshida, H. & Nakamura, H. Effect of in-vivo supplementation with low-dose vitamin E on susceptibility of low-density lipoprotein and high-density lipoprotein to oxidative modification. J Am Coll Nutr. 14, 46-52 (1995).
10. Suzukawa, M., Abbey, M., Clifton, P. & Nestel, P. J. Effects of supplementing with vitamin E on the uptake of low density lipoprotein and the stimulation of cholesteryl ester formation in macrophages. Atherosclerosis. 110, 77-86 (1994).
11. Huang, Z. G., Liang, C., Han, S. F. & Wu, Z. G. Vitamin E ameliorates ox-LDLinduced foam cells formation through modulating the activities of oxidative stress-induced NF-kB pathway. Mol Cell Biochem. 363, 11-19 (2012).
12. Praticò, D., Tangirala, R. K., Rader, D. J., Rokach, J. & FitzGerald, G. A. Vitamin E suppresses isoprostane generation in vivo and reduces atherosclerosis in ApoEdeficient mice. Nat Med. 4, 1189-1192 (1998).
13. Kris-Etherton, P.M., Lichtenstein,A.H., Howard, B. V., Steinberg, D.&Witztum, J. L. Antioxidant vitamin supplements and cardiovascular disease. Circulation. 110, 637-641 (2004).
14. Haidari, M., Javadi, E., Kadkhodaee, M. & Sanati, A. Enhanced susceptibility to oxidation and diminished vitamin E content of LDL from patients with stable coronary artery disease. Clin Chem. 47, 1234-1240 (2001).
15. Teissier, E. et al. Rapid quantification of alpha-tocopherol in plasma and low- and high-density lipoproteins. Clin Chem. 42, 430-435 (1996).
16. Hirowatari, Y. et al. Analysis of cholesterol levels in lipoprotein(a) with anionexchange chromatography. J Lipid Res. 51, 1237-1243 (2010).
17. Hirowatari, Y., Yoshida, H., Kurosawa, H., Doumitu, K. I. & Tada, N. Measurement of cholesterol of major serum lipoprotein classes by anionexchange HPLC with perchlorate ion-containing eluent. J Lipid Res. 44, 1404-1412 (2003).
18. Yoshida, H., Ishikawa, T. & Nakamura, H. Vitamin E/lipid peroxide ratio and susceptibility of LDL to oxidative modification in non-insulin-dependent diabetes mellitus. Arterioscler Thromb Vasc Biol. 17, 1438-1446 (1997).
19. Kleinveld, H. A., Hak-Lemmers, H. L., Stalenhoef, A. F. & Demacker, P. N. Improved measurement of low-density-lipoprotein susceptibility to copperinduced oxidation: application of a short procedure for isolating low-density lipoprotein. Clin Chem. 38, 2066-2072 (1992).
20. Itabe, H. & Ueda, M. Measurement of plasma oxidized low-density lipoprotein and its clinical implications. J Atheroscler Thromb. 14, 1-11 (2007).
21. Tsimikas, S. et al. Percutaneous coronary intervention results in acute increases in oxidized phospholipids and lipoprotein(a): short-term and long-term immunologic responses to oxidized low-density lipoprotein. Circulation. 109, 3164-3170 (2004).
22. Holvoet, P., Vanhaecke, J., Janssens, S., Van de Werf, F. & Collen, D. Oxidized LDL and malondialdehyde-modified LDL in patients with acute coronary syndromes and stable coronary artery disease. Circulation. 98, 1487-1494 (1998).
23. Carr, T. P., Traber, M. G., Haines, J. L., Kayden, H. J., Parks, J. S. & Rudel, L. L. Interrelationships of alpha-tocopherol with plasma lipoproteins in African green monkeys: effects of dietary fats. J Lipid Res. 34, 1863-1871 (1993).
24. Bub, A. et al. Moderate intervention with carotenoid-rich vegetable products reduces lipid peroxidation in men. J Nutr. 130, 2200-2206 (2000).
25. Parks, E. J. et al. Dependence of plasma a-tocopherol flux on very low-density triglyceride clearance in humans. Free Radic Biol Med. 29, 1151-1159 (2000).
26. Quiñones-Galvan, A. et al. Effective blood pressure treatment improves LDLcholesterol susceptibility to oxidation in patients with essential hypertension. J Intern Med. 250, 322-326 (2001).
27. Khan, B. V., Navalkar, S., Khan, Q. A., Rahman, S. T. & Parthasarathy, S. Irbesartan, an angiotensin type 1 receptor inhibitor, regulates the vascular oxidative state in patients with coronary artery disease. J Am Coll Cardiol. 38, 1662-1667 (2001).
28. Havel, R. J., Eder, H. A. & Bragdon, J. H. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest. 34, 1345-1353 (1995).
29. Schumaker, V. N. & Puppione, D. L. Sequential flotation ultracentrifugation. Methods Enzymol. 128, 155-170 (1986).
30. Teissier, E. et al. Rapid quantification of alpha-tocopherol in plasma and low- and high-density lipoproteins. Clin Chem. 42, 430-435 (1996).
31. Yoshida, H., Ishikawa, T. & Nakamura, H. Vitamin E/lipid peroxide ratio and susceptibility of LDL to oxidative modification in non-insulin-dependent diabetes mellitus. Arterioscler Thromb Vasc Biol. 17, 1438-46 (1997).
32. Kleinveld, H. A., Hak-Lemmers, H. L., Stalenhoef, A. F. & Demacker, P. N. Improved measurement of low-density-lipoprotein susceptibility to copperinduced oxidation: application of a short procedure for isolating low-density lipoprotein. Clin Chem. 38, 2066-72 (1992).